Publication date: February 19, 2026. In a ClinicalTrials.gov record a study from Peking University Third Hospital aims to validate a wearable device based remote rehabilitation system for patients after rotator cuff surgery. The conditions targeted include rotator cuff tear. The trial lists two interventions device based rehabilitation using a wearable device and offline traditional rehabilitation. The study is not yet recruiting at this time.In this article we provide an overview of the trial and explain why it matters to patients clinicians and regulators. The content follows a medical device regulation oriented approach with focus on intended use performance and safety as described by the sponsor.In this article: What is the study about How is the study designed What is the regulatory context Why does this matter FAQ
What is the study about
The record details a prospective evaluation of a wearable device based system intended for remote rehabilitation after a rotator cuff injury. The focus is on improving access to care after surgery and supporting adherence to prescribed therapy, while ensuring patient safety informs the performance profile of the device.
What conditions are studied
The listed condition is rotator cuff tear, a common shoulder injury that can require operative repair. The trial context uses this terminology from clinical trial registries.
What interventions are involved
The trial lists two intervention options. One is device based rehabilitation delivered through a wearable device. The other is offline traditional rehabilitation. The design implies a comparison of a digital therapy modality with standard care, under the same surgical context.
How is the study designed
Details in the registry suggest a device oriented rehabilitation approach that may include remote monitoring and guided therapy. The exact study design and endpoints are not described in the source text. The report notes the sponsor and the non recruiting status, which provides transparency about progress expectations.
What are the intervention arms
The record specifies two arms or options wearable device rehabilitation and offline traditional rehabilitation. The registry does not disclose randomization or sample size at this time.
What is the regulatory context for this device
The described use maps to a device intended for rehabilitation after shoulder surgery. In a regulatory oriented read the narrative emphasizes intended use performance and safety as part of the data package investigators seek to assemble. The sponsor states the device is for patient rehabilitation, with safety as a key consideration during validation.
While the registry does not report clearance status the description aligns with the requirement to establish a clear intended use and credible performance data prior to market entry or further clinical evaluation.
Why is this important for patients and clinicians
Remote rehabilitation tools have potential to improve access to care after rotator cuff surgery particularly for patients with limited mobility or geographic barriers. If the study confirms acceptable safety and performance clinicians may have an option to prescribe wearable guided therapy as an adjunct or alternative to in person sessions. Regulators will look for rigorous data on device reliability user safety data security and clinical relevance before broad adoption.
FAQ
- What is the purpose of this trial The registry describes a wearable device based remote rehabilitation approach for postoperative rotator cuff injury. The emphasis is on safety and performance during rehabilitation.
- Who funds or sponsors the study The sponsor listed is Peking University Third Hospital, without recruitment results at this time.
- What is the status of recruitment The record indicates not yet recruiting at the time of listing.
- Where can I view full details The ClinicalTrials.gov page is provided in the source text.
Conclusion and implications for readers
The trial record reflects ongoing validation of a wearable rehabilitation system for postoperative rotator cuff injury. If outcomes show safety and meaningful performance the device may support remote therapy strategies and influence future device development and regulatory submissions. Readers should monitor the sponsor and registry for updates.
Disclaimer for professionals
This article is for regulatory and clinical readers. It is not legal advice. Review of the cited registry and any updates should be interpreted in the light of local regulations and the MDR framework.
Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07412184?term=medical+device